scholarly journals Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021

2021 ◽  
Vol 70 (37) ◽  
Author(s):  
Shaun J. Grannis ◽  
Elizabeth A. Rowley ◽  
Toan C. Ong ◽  
Edward Stenehjem ◽  
Nicola P. Klein ◽  
...  
Keyword(s):  
Emergency Department ◽  
Vaccine Effectiveness ◽  
Urgent Care ◽  
Care Clinic ◽  
Urgent Care Clinic

scholarly journals Syncope: Assessment of risk and an approach to evaluation in the emergency department and urgent care clinic

2015 ◽  
Vol 15 (2) ◽  
pp. 103-109 ◽  
Author(s):  
Baris Akdemir ◽  
Balaji Krishnan ◽  
Tunay Senturk ◽  
David G. Benditt
Keyword(s):  
Emergency Department ◽  
Urgent Care ◽  
Care Clinic ◽  
Urgent Care Clinic

scholarly journals Patient Perspectives on the Experience of Being Newly Diagnosed with HIV in the Emergency Department/Urgent Care Clinic of a Public Hospital

PLoS ONE ◽  
2013 ◽  
Vol 8 (8) ◽  
pp. e74199 ◽  
Author(s):  
Katerina A. Christopoulos ◽  
Amina D. Massey ◽  
Andrea M. Lopez ◽  
C. Bradley Hare ◽  
Mallory O. Johnson ◽  
...  
Keyword(s):  
Emergency Department ◽  
Public Hospital ◽  
Patient Perspectives ◽  
Urgent Care ◽  
Newly Diagnosed ◽  
Care Clinic ◽  
Urgent Care Clinic

scholarly journals Impact of a Cancer Urgent Care Clinic on Regional Emergency Department Visits

2019 ◽  
Vol 15 (6) ◽  
pp. e501-e509
Author(s):  
Arthur S. Hong ◽  
Thomas Froehlich ◽  
Stephanie Clayton Hobbs ◽  
Simon J. Craddock Lee ◽  
Ethan A. Halm
Keyword(s):  
Emergency Department ◽  
Emergency Department Visits ◽  
Urgent Care ◽  
Comprehensive Cancer Center ◽  
Secondary Outcome ◽  
Cancer Center ◽  
Control Group ◽  
Interrupted Time Series Analysis ◽  
Care Clinic ◽  
Urgent Care Clinic

PURPOSE: Did the creation of an urgent care clinic specifically for patients with cancer affect emergency department visits among adults newly diagnosed with cancer? PATIENTS AND METHODS: We applied an interrupted time series analysis to adjusted monthly emergency department visits made by adults age 18 years or older who were diagnosed with cancer between 2009 and 2016 at a comprehensive cancer center. Cancer registry patients were linked to a longitudinal regional database of emergency department and hospital visits. Because the urgent care clinic was closed on weekends, we took advantage of the natural experiment by comparing weekend visits as a control group. Our primary outcome was emergency department visits within 180 days after a cancer diagnosis, compiled as adjusted monthly rates of emergency department visits per 1,000 patient-months. We analyzed subsequent hospitalizations as a secondary outcome. RESULTS: The rate of weekday emergency department visits was increasing at a rate of 0.43 visits (95% CI, 0.29 to 0.57 visits) per month before May 2012, then fell in half to a rate of 0.19 visits (95% CI, 0.11 to 0.28 visits) per month ( P = .007) after the urgent care clinic was established. In contrast, the weekend visit rate was growing at a rate of 0.08 visits (95% CI, −0.03 to 0.19 visits) per month before May 2012 and 0.05 (95% CI, −0.02 to 0.13 visits; P = .533) afterward. By the end of 2016, there were 15.3 fewer monthly weekday emergency department visits than expected ( P = .005). Trends in weekday hospitalizations were not significantly changed. CONCLUSION: Although only one in eight emergency department–visiting patients also used the urgent care clinic, the growth rate of emergency department visits fell by half after the urgent care clinic was established.

Practical Assessment and Treatment of the Patient with Headaches in the Emergency Department and Urgent Care Clinic

Neurology ◽  
2013 ◽  
Vol 80 (5) ◽  
pp. 509-510
Author(s):  
J. L. Beams ◽  
T. D. Rozen
Keyword(s):  
Emergency Department ◽  
Urgent Care ◽  
Care Clinic ◽  
Assessment And Treatment ◽  
Urgent Care Clinic

Urgent care in the community: an observational study

2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
John Adie ◽  
Wayne Graham ◽  
Kerron Bromfield ◽  
Bianca Maiden ◽  
Sam Klaer ◽  
...  
Keyword(s):  
Emergency Department ◽  
Urgent Care ◽  
Chart Audit ◽  
Community Based ◽  
Pathology Laboratory ◽  
Care Clinic ◽  
Content Type ◽  
Client Group ◽  
Urgent Care Clinic ◽  
Electrocardiogram Ecg

PurposeThis case study describes a community-based urgent care clinic in a general practitioner (GP) super clinic in South East Queensland.Design/methodology/approachThis retrospective chart audit describes patient demographic characteristics, types of presentations and management for Sundays in 2015.FindingsThe majority of patients (97%) did not require admission to hospital or office investigations (95%) and presented with one condition (94%). Of the presentations, 66.5% were represented by 30 conditions. Most patients received a prescription (57%), some were referred to the pathology laboratory (15%) and some were referred to radiology (12%). A majority (54%) of patients presented in the first three hours. Approximately half (51%) of patients presenting were aged under 25. More females (53%) presented than males. A majority (53%) lived in the same postcode as the clinic. The three most common office tests ordered were urinalysis, electrocardiogram (ECG) and urine pregnancy test. Some patients (19%) needed procedures, and only 3% were referred to hospital.Research limitations/implicationsThe study offers analysis of the client group that can be served by an urgent care clinic in a GP super clinic on a Sunday. The study provides an option for emergency department avoidance.Originality/valueDespite calls for more research into community-based urgent care clinics, little is known in Australia about what constitutes an urgent care clinic. The study proposes a classification system for walk-in presentations to an urgent care clinic, which is comparable to emergency department presentations.

The Quality of Pharmacotherapy in Older Veterans Discharged from the Emergency Department or Urgent Care Clinic

2007 ◽  
Vol 55 (9) ◽  
pp. 1339-1348 ◽  
Author(s):  
S. Nicole Hastings ◽  
Richard J. Sloane ◽  
Kenneth C. Goldberg ◽  
Eugene Z. Oddone ◽  
Kenneth E. Schmader
Keyword(s):  
Emergency Department ◽  
Urgent Care ◽  
Care Clinic ◽  
Urgent Care Clinic

scholarly journals Notes from the Field: Group A Streptococcal Pharyngitis Misdiagnoses at a Rural Urgent-Care Clinic — Wyoming, March 2015

2016 ◽  
Vol 64 (50-51) ◽  
pp. 1383-1385 ◽  
Author(s):  
Alexia Harrist ◽  
Clayton Van Houten ◽  
Stanford T. Shulman ◽  
Chris Van Beneden ◽  
Tracy Murphy
Keyword(s):  
Streptococcal Pharyngitis ◽  
Urgent Care ◽  
Care Clinic ◽  
Group A ◽  
Urgent Care Clinic

scholarly journals Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19

Blood ◽  
2021 ◽  
Vol 138 (Supplement 1) ◽  
pp. 4179-4179
Author(s):  
Shivani Rao ◽  
Nicole K. Yun ◽  
James L. Coggan ◽  
Peter Wu ◽  
Teresa O'Brien ◽  
...  
Keyword(s):  
Acute Care ◽  
Statistical Significance ◽  
Advisory Board ◽  
Urgent Care ◽  
Care Utilization ◽  
Novel Therapies ◽  
Care Clinic ◽  
Acute Care Utilization ◽  
Urgent Care Clinic ◽  
Acute Medical Care

Abstract Introduction In sickle cell disease (SCD), the polymerization of deoxygenated HbS fundamentally alters the structure of the erythrocyte, producing the sickle cell that is characteristic of the disease. Clinical manifestations often perceived in patients suffering from SCD include vaso-occlusion, anemia, and hemolysis. Due to these sequelae, patients frequent the emergency room (ER), urgent care clinic, and hospital. Voxelotor, an oral medication approved by the Food and Drug Administration (FDA) in 2019 for the treatment of SCD, directly targets the pathophysiology of SCD by inhibiting deoxygenated HbS polymerization. Results of the Phase III HOPE trial indicate that the drug can increase hemoglobin levels and reduce markers of hemolysis as well as the incidence of worsening anemia in patients with SCD (Vichinsky et al. N Engl J Med 2019). The COVID-19 pandemic has posed several challenges for patients with SCD in 2020. Amid the pandemic, patients continued to seek out acute medical care, including care in the ER, urgent care clinics, and hospital. The aim of this study was to determine whether utilization of acute medical care differed for patients who received voxelotor before and after therapy in 2020. We also evaluated the utilization of healthcare through telemedicine platforms to facilitate access to novel therapies such as voxelotor for patients with SCD. Methods 13 patients (≥18 years of age as of January 1, 2020) with SCD who had begun treatment with voxelotor between January 1, 2020 and December 31, 2020 were included in the initial analysis. Six patients were excluded from final analysis: three discontinued treatment due to side effects, one was noncompliant with treatment, and two were lost to follow-up. Acute care utilization, measured by the number of times each patient visited the ER, urgent care clinic, and hospital was compared for each patient in the period six months prior to their first dose of voxelotor and in the period six months after their last dose of the drug in 2020 using paired t-tests and Wilcoxon matched-pairs signed rank tests. Demographic information and the type of visit at which patients agreed to proceed with voxeletor was recorded for each patient. Simple linear regressions and multiple regressions controlled for covariates, defined as sex, BMI, age, type of insurance coverage, and duration of treatment. Results All seven (100%) patients discussed voxelotor treatment with their provider during a telehealth video visit. In the period before initiating treatment, patients frequented the ER an average of 2.71 (SD=6.75) times. In the six months after their last dose, patients visited the ER less than they had in the period prior to treatment, on average 0.57 (SD=0.79) times. This difference did not achieve statistical significance (p>0.9999). The mean number of visits to the urgent care clinic in the six months before treatment was 2.71 (SD=6.75) compared to 2 (SD=4) in the period after patients' last dose in 2020. This finding was not statistically significant (p>0.9999). Hospitalizations, on average, decreased significantly from 5.14 (SD=2.34) in the six months before starting treatment to 1.57 (SD=0.98) after ending therapy for 2020 (p=0.0015). Covariates did not have an effect on the differences in acute care utilization before treatment and after last treatment in 2020. Conclusions The findings of this study imply that treatment with voxelotor was associated with a decrease in the frequency of hospitalizations for the seven patients analyzed. This finding can potentially be attributed to the efficacy of voxelotor in improving anemia and reducing complications associated with SCD. While the difference between ER visits and urgent care visits before treatment and after the last dose in 2020 did not achieve statistical significance, likely due to small sample size, the data does suggest a reduction in both outcomes. In addition, the observation that all visits in which patient and provider discussed and initiated treatment were virtual support the use of telemedicine technology to improve access to multidisciplinary care and novel therapies for SCD patients. The impact of voxelotor treatment will continue to be assessed in SCD patients at our institution, and more data from clinical encounters will lead to a greater understanding of the efficacy of voxelotor. Figure 1 Figure 1. Disclosures Jain: GBT: Speakers Bureau; Novartis: Speakers Bureau; Sanofi: Other: advisory board; Argenx: Other: advisory board; DOVA: Other: advisory board.

Sign in / Sign up

Export Citation Format

Share Document